Multicentre evaluation of a new point-of-care test for the quantitative determination of D-dimer
Carl‐Erik Dempfle(University of Mannheim), Rainer Zerback(Roche Pharma AG (Germany)), Peter Quehenberger, Ingo Besenthal(Universitätsklinikum Tübingen), Jochen Gehrke(St. Josefs Hospital), Marc Schraml(Heidelberg University), Wolfgang Korte(Kantonsspital St. Gallen), Erich Minar(Medical University of Vienna), Ilse Schulz(Roche Pharma AG (Germany)), Roland Hansen, Martin Risch(University of Liechtenstein), Sylvia Handler(Oklahoma State University Center for Health Sciences)
Cited by 36
Related Papers
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length
|Circulation|2007|515
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
|Circulation|2007|500
The Risk of Recurrent Venous Thromboembolism in Men and Women
|New England Journal of Medicine|2004|478